These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28356931)

  • 1. MicroRNA-320a downregulation mediates human liver cancer cell proliferation through the Wnt/β-catenin signaling pathway.
    Lu C; Liao Z; Cai M; Zhang G
    Oncol Lett; 2017 Feb; 13(2):573-578. PubMed ID: 28356931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA-320a inhibits tumor proliferation and invasion by targeting c-Myc in human hepatocellular carcinoma.
    Xie F; Yuan Y; Xie L; Ran P; Xiang X; Huang Q; Qi G; Guo X; Xiao C; Zheng S
    Onco Targets Ther; 2017; 10():885-894. PubMed ID: 28243124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-300 inhibits the growth of hepatocellular carcinoma cells by downregulating CREPT/Wnt/β-catenin signaling.
    Bai J; Gao Y; Du Y; Yang X; Zhang X
    Oncol Lett; 2019 Oct; 18(4):3743-3753. PubMed ID: 31516587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
    Sun J; Liu L; Zou H; Yu W
    Yonsei Med J; 2019 Oct; 60(10):905-913. PubMed ID: 31538425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
    Quan H; Li B; Yang J
    Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/β-catenin signaling in human hepatocellular carcinoma.
    Zeng XC; Liu FQ; Yan R; Yi HM; Zhang T; Wang GY; Li Y; Jiang N
    Mol Cancer; 2014 Dec; 13():261. PubMed ID: 25491321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
    Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting β-catenin.
    Sun JY; Huang Y; Li JP; Zhang X; Wang L; Meng YL; Yan B; Bian YQ; Zhao J; Wang WZ; Yang AG; Zhang R
    Biochem Biophys Res Commun; 2012 Apr; 420(4):787-92. PubMed ID: 22459450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
    Cao F; Yin LX
    Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-320a is downregulated in non-small cell lung cancer and suppresses tumor cell growth and invasion by directly targeting insulin-like growth factor 1 receptor.
    Wang J; Shi C; Wang J; Cao L; Zhong L; Wang D
    Oncol Lett; 2017 May; 13(5):3247-3252. PubMed ID: 28521431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-320a serves as a negative regulator in the progression of gastric cancer by targeting RAB14.
    Li Y; Liu H; Shao J; Xing G
    Mol Med Rep; 2017 Sep; 16(3):2652-2658. PubMed ID: 28713899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory role of microRNA-320a in the proliferation, migration, invasion, and apoptosis of trophoblasts and endothelial cells by targeting estrogen-related receptor γ.
    Liu RH; Meng Q; Shi YP; Xu HS
    J Cell Physiol; 2018 Jan; 234(1):682-691. PubMed ID: 30216440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8.
    Li M; Tian L; Ren H; Chen X; Wang Y; Ge J; Wu S; Sun Y; Liu M; Xiao H
    J Transl Med; 2015 Aug; 13():271. PubMed ID: 26286725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-320a suppresses colorectal cancer progression by targeting Rac1.
    Zhao H; Dong T; Zhou H; Wang L; Huang A; Feng B; Quan Y; Jin R; Zhang W; Sun J; Zhang D; Zheng M
    Carcinogenesis; 2014 Apr; 35(4):886-95. PubMed ID: 24265291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-381 suppresses cell growth and invasion by targeting the liver receptor homolog-1 in hepatocellular carcinoma.
    Zhang Q; Zhao S; Pang X; Chi B
    Oncol Rep; 2016 Mar; 35(3):1831-40. PubMed ID: 26677080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-214 Suppresses Ovarian Cancer by Targeting β-Catenin.
    Liu Y; Lin J; Zhai S; Sun C; Xu C; Zhou H; Liu H
    Cell Physiol Biochem; 2018; 45(4):1654-1662. PubMed ID: 29486472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-320a regulates high mobility group box 1 expression and inhibits invasion and metastasis in hepatocellular carcinoma.
    Lv G; Wu M; Wang M; Jiang X; Du J; Zhang K; Li D; Ma N; Peng Y; Wang L; Zhou L; Zhao W; Jiao Y; Gao X; Hu Z
    Liver Int; 2017 Sep; 37(9):1354-1364. PubMed ID: 28317284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-370-3p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting β-catenin.
    Peng Z; Wu T; Li Y; Xu Z; Zhang S; Liu B; Chen Q; Tian D
    Brain Res; 2016 Aug; 1644():53-61. PubMed ID: 27138069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of MiR-212 Inhibits Migration and Tumorigenicity and Inactivates Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma.
    Jia P; Wei G; Zhou C; Gao Q; Wu Y; Sun X; Li X
    Technol Cancer Res Treat; 2018 Jan; 17():1533034618765221. PubMed ID: 29618288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis.
    Zhang Z; Li X; Sun W; Yue S; Yang J; Li J; Ma B; Wang J; Yang X; Pu M; Ruan B; Zhao G; Huang Q; Wang L; Tao K; Dou K
    Cancer Lett; 2017 Jul; 397():33-42. PubMed ID: 28288874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.